(2024). How common are side effects of treatment to prevent gout flares when starting allopurinol?. Bmj, 384, q514. http://doi.org/10.1136/bmj.q514
. E. Roddy
First name
E.
Last name
Roddy
(2023). Safety of colchicine and NSAID prophylaxis when initiating urate-lowering therapy for gout: propensity score-matched cohort studies in the UK Clinical Practice Research Datalink. Ann Rheum Dis. http://doi.org/10.1136/ard-2023-224154
. (2022). Treat-to-target urate-lowering therapy and hospitalisations for gout: results from a nationwide cohort study in England. Rheumatology (Oxford). http://doi.org/10.1093/rheumatology/keac638
. (2014). Risk of vascular events in patients with polymyalgia rheumatica. Cmaj. http://doi.org/10.1503/cmaj.140266
. (2015). Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205252
. (2017). Gout and subsequent erectile dysfunction: a population-based cohort study from England. Arthritis Res Ther. http://doi.org/10.1186/s13075-017-1322-0
. (2017). Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink. Medicine (Baltimore). http://doi.org/10.1097/md.0000000000006177
. (2017). Factors Influencing Allopurinol Initiation in Primary Care. Ann Fam Med. http://doi.org/10.1370/afm.2137
. (2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. http://doi.org/10.1186/s13075-018-1746-1
. (2018). Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. http://doi.org/10.1186/s12916-017-0987-1
.